Prophylaxis Versus Preemptive Therapy for Prevention of Human Cytomegalovirus Disease in Pediatric Liver Transplant Recipients

被引：0
|
作者：
Gerna, Giuseppe [1 ]
Lilleri, Daniele [1 ]
Torre, Giuliano [2 ]
机构：
[1] Policlin San Matteo, Fdn IRCSS, Serv Virol, I-27100 Pavia, Italy
[2] Osped Riuniti Bergamo, Div Pediat, I-24100 Bergamo, Italy
来源：
TRANSPLANTATION | 2009年 / 87卷 / 02期
关键词：
D O I：
10.1097/TP.0b013e3181938beb
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：306 / 307
页数：2
相关论文
共 50 条
  • [21] Preemptive Therapy for the Prevention of Cytomegalovirus Disease in Renal Transplant Recipients: Our Preliminary Experience
    Paudice, N.
    Mehmetaj, A.
    Zanazzi, M.
    Moscarelli, L.
    Piperno, R.
    Di Maria, L.
    Bertoni, E.
    Salvadori, M.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (04) : 1204 - 1206
  • [22] Preemptive therapy is not adequate for prevention of cytomegalovirus disease in pancreas-kidney transplant recipients
    Lopez-Medrano, F.
    Rueda, B.
    Lizasoain, M.
    Juan, R. San
    Folgueira, D.
    Andres, A.
    Morales, J. M.
    Jimenez, C.
    Meneu, J. C.
    Aguado, J. M.
    TRANSPLANT INFECTIOUS DISEASE, 2009, 11 (05) : 400 - 404
  • [23] Cytomegalovirus prevention: Prophylaxis and preemptive therapy
    Humar, Atul
    TRANSPLANTATION, 2007, 84 (06) : S11 - S14
  • [24] Preemptive Therapy for Cytomegalovirus Disease in Liver Transplant Recipients-A Single Center Experience
    Alvey, N.
    Tieman, J.
    Diamond, A.
    Hodowanec, A.
    Simon, D.
    Fayek, S.
    Hertl, M.
    Olaitan, O.
    Hollinger, E.
    Chan, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [25] Preemptive Therapy vs Antiviral Prophylaxis in Cytomegalovirus-Seronegative Liver Transplant Recipients With Seropositive Donors
    Roberts, Matthew B.
    Gandhi, Ronak G.
    Kotton, Camille N.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (11): : 1107 - 1108
  • [26] Preemptive treatment for the prevention of cytomegalovirus disease - In lung and heart transplant recipients
    Egan, JJ
    Lomax, J
    Barber, L
    Lok, SS
    Martyszczuk, R
    Yonan, N
    Fox, A
    Deiraniya, AK
    Turner, AJ
    Woodcock, AA
    TRANSPLANTATION, 1998, 65 (05) : 747 - 752
  • [27] Efficacy and safety of valgancyclovir as preemptive therapy for the prevention of cytomegalovirus disease in solid organ transplant recipients
    Díaz-Pedroche, C
    Lumbreras, C
    Del Valle, P
    San Juan, R
    Hernando, S
    Folgueira, D
    Andrés, A
    Delgado, J
    Meneu, JC
    Morales, JM
    Moreno, E
    Aguado, JM
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (09) : 3766 - 3767
  • [28] Prevention of cytomegalovirus disease in solid organ transplant patients: Prophylactic versus preemptive therapy
    Baillie, G. Mark
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2006, 63 : S10 - S16
  • [29] Prevention of cytomegalovirus disease in solid organ transplant patients: Prophylactic versus preemptive therapy
    Baillie, G. Mark
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2006, 63 : S10 - S16
  • [30] Cytomegalovirus prophylaxis in liver transplant recipients
    Molmenti, EP
    Devera, J
    Paredes, MM
    Holochek, MJ
    Lees, L
    Eustace, JA
    Diehl, AM
    Thuluvath, PJ
    Rai, R
    Montgomery, RA
    Arrazola, L
    Updyke, G
    Cooper, M
    Falta, E
    Karp, S
    Johnson, K
    Klein, J
    Klein, AS
    GASTROENTEROLOGY, 2002, 123 (01) : 82 - 83
12345